Singapore Institute of Advanced Medicine (SGX:9G2) loss after tax and total comprehensive loss from continuing operations for the six moths ended June 30 widened 67% year over year to SG$16.2 million from SG$9.7 million, a filing with the Singapore Exchange said on Tuesday.
Revenue remained relatively unchanged at SG$8.1 million for the period despite increase in revenue from radiation therapy and medical oncology services.
Shares of the medical services company plunged nearly 15% in recent trading.
Price (SGD): S$67.60, Change: S$+0.39, Percent Change: +0.58%